Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Trisail Medical

SME

www.trisailmedical.com/Singapore, Singapore
5 profile visits

About

Trisail Medical, a spin-off from the National Heart Centre Singapore, is developing the world's simplest and fastest transcatheter medical device to treat tricuspid regurgitation, a heart valve disease affecting >60 million people globally. The company has strong pre-clinical safety data and is raising Series A financing to complete First-in-Human studies. We welcome potential investors and collaborators who wish to learn more about our technology and company to reach out and discuss the opportunity.

Areas of activity

What is your business/industry sector?

Healthcare

Representatives

Srinivas Bhylahalli

CEO

Trisail Medical

Marketplace (1)

  • Project cooperation

    Development and testing of novel heart valve repair device

    Trisail Medical is developing a novel transcatheter tricuspid valve repair device. We welcome partners with interest in cardiac implant/heart valve area. Opportunity for joint product development, testing,clinical development, grants funding & licensing.

    • Execution
    • Technical
    • Healthcare
    • EU projects
    • Biotech, Pharma and Cosmetics
    Author

    Srinivas Bhylahalli

    CEO at Trisail Medical

    Singapore, Singapore